RHÖN-KLINIKUM Aktiengesellschaft Market Cap ($876.89 Million)
Market Cap & Net Worth: RHÖN-KLINIKUM Aktiengesellschaft (RHK)
RHÖN-KLINIKUM Aktiengesellschaft market cap. RHÖN-KLINIKUM Aktiengesellschaft (XETRA:RHK) has a market capitalization of $876.89 Million (€750.06 Million) as of October 31, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #9095 globally and #1168 in its home market, demonstrating a -1.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RHÖN-KLINIKUM Aktiengesellschaft's stock price €14.40 by its total outstanding shares 66938470 (66.94 Million).
RHÖN-KLINIKUM Aktiengesellschaft Market Cap History (2015–2026)
RHÖN-KLINIKUM Aktiengesellschaft market cap history from 2015 to 2026. Data shows change from $2.01 Billion to $1.13 Billion (-4.55% CAGR). Check RHK live share price for real-time trading data and today's change.
RHÖN-KLINIKUM Aktiengesellschaft Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RHÖN-KLINIKUM Aktiengesellschaft's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash efficiency ratio of RHÖN-KLINIKUM Aktiengesellschaft for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.68x
RHÖN-KLINIKUM Aktiengesellschaft's market cap is 0.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
25.09x
RHÖN-KLINIKUM Aktiengesellschaft's market cap is 25.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.01 Billion | $1.11 Billion | $85.38 Million | 1.81x | 23.55x |
| 2016 | $1.92 Billion | $1.18 Billion | $56.43 Million | 1.63x | 34.04x |
| 2017 | $2.27 Billion | $1.21 Billion | $35.15 Million | 1.87x | 64.47x |
| 2018 | $1.69 Billion | $1.23 Billion | $48.99 Million | 1.37x | 34.43x |
| 2019 | $1.35 Billion | $1.30 Billion | $43.28 Million | 1.04x | 31.24x |
| 2020 | $1.28 Billion | $1.36 Billion | $1.45 Million | 0.94x | 879.40x |
| 2021 | $1.11 Billion | $1.40 Billion | $28.30 Million | 0.79x | 39.30x |
| 2022 | $1.18 Billion | $1.45 Billion | $25.14 Million | 0.82x | 47.06x |
| 2023 | $782.58 Million | $1.73 Billion | $38.71 Million | 0.45x | 20.22x |
| 2024 | $1.09 Billion | $1.60 Billion | $43.35 Million | 0.68x | 25.09x |
Competitor Companies of RHK by Market Capitalization
Companies near RHÖN-KLINIKUM Aktiengesellschaft in the global market cap rankings as of October 31, 2026. See RHK net asset quality index to understand what proportion of total assets are financed by equity.
Key companies related to RHÖN-KLINIKUM Aktiengesellschaft by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of RHÖN-KLINIKUM Aktiengesellschaft (2015–2026)
Market capitalization of RHÖN-KLINIKUM Aktiengesellschaft from 2015 to today. Between 2015 and today, RHÖN-KLINIKUM Aktiengesellschaft's market cap moved from $2.01 Billion to $ 1.13 Billion, with a yearly change of -4.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.13 Billion | +13.39% |
| 2025 | €993.88 Million | -8.63% |
| 2024 | €1.09 Billion | +39.00% |
| 2023 | €782.58 Million | -33.86% |
| 2022 | €1.18 Billion | +6.40% |
| 2021 | €1.11 Billion | -12.85% |
| 2020 | €1.28 Billion | -5.61% |
| 2019 | €1.35 Billion | -19.86% |
| 2018 | €1.69 Billion | -25.56% |
| 2017 | €2.27 Billion | +17.98% |
| 2016 | €1.92 Billion | -4.46% |
| 2015 | €2.01 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of RHÖN-KLINIKUM Aktiengesellschaft was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $876.89 Million USD |
| MoneyControl | $876.89 Million USD |
| MarketWatch | $876.89 Million USD |
| marketcap.company | $876.89 Million USD |
| Reuters | $876.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.